Detalhe da pesquisa
1.
Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alterations.
Oncologist
; 25(1): e160-e169, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31395751
2.
Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma.
Haematologica
; 105(3): e116-e120, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31320555
3.
A phase II pharmacodynamic study of erlotinib in patients with advanced non-small cell lung cancer previously treated with platinum-based chemotherapy.
Clin Cancer Res
; 14(12): 3867-74, 2008 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18559607
4.
Mechanistic Insights of an Immunological Adverse Event Induced by an Anti-KIT Antibody Drug Conjugate and Mitigation Strategies.
Clin Cancer Res
; 24(14): 3465-3474, 2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29615457
5.
LJM716 in Japanese patients with head and neck squamous cell carcinoma or HER2-overexpressing breast or gastric cancer.
Cancer Chemother Pharmacol
; 79(1): 131-138, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27942917